Human pharmaceuticals for the treatment of cancer, excluding human pharmaceuticals for the treatment of autoimmune conditions, rheumatoid arthritis, and multiple sclerosis
REGISTERED
on 10 Nov 2023
ISTRELZO
JOHNSON & JOHNSON
2040772 · 20 Jul 2020
005
Class 005
Pharmaceutical Products
Human pharmaceuticals for the treatment of cancer, excluding human pharmaceuticals for the treatment of autoimmune conditions, rheumatoid arthritis, and multiple sclerosis
Human pharmaceuticals for the treatment of cancer, excluding human pha...
